| Year |
Citation |
Score |
| 2020 |
Donovan N, Mecca A, Smith G, Gatchel J. Molecular Imaging In Alzheimer'S Disease: Linking Pathologic, Neurotransmitter, Synaptic And Clinical Findings Relevant To Geriatric Psychiatry American Journal of Geriatric Psychiatry. 28. DOI: 10.1016/J.Jagp.2020.01.017 |
0.302 |
|
| 2013 |
Perroud B, Jafar-Nejad P, Wikoff WR, Gatchel JR, Wang L, Barupal DK, Crespo-Barreto J, Fiehn O, Zoghbi HY, Kaddurah-Daouk R. Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effects. Plos One. 8: e70610. PMID 23936457 DOI: 10.1371/Journal.Pone.0070610 |
0.523 |
|
| 2012 |
Chen YC, Gatchel JR, Lewis RW, Mao CA, Grant PA, Zoghbi HY, Dent SY. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model. Human Molecular Genetics. 21: 394-405. PMID 22002997 DOI: 10.1093/hmg/ddr474 |
0.474 |
|
| 2008 |
Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nature Neuroscience. 11: 1137-9. PMID 18758459 DOI: 10.1038/Nn.2183 |
0.581 |
|
| 2008 |
Gatchel JR, Watase K, Thaller C, Carson JP, Jafar-Nejad P, Shaw C, Zu T, Orr HT, Zoghbi HY. The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7. Proceedings of the National Academy of Sciences of the United States of America. 105: 1291-6. PMID 18216249 DOI: 10.1073/Pnas.0711257105 |
0.621 |
|
| 2007 |
Watase K, Gatchel JR, Sun Y, Emamian E, Atkinson R, Richman R, Mizusawa H, Orr HT, Shaw C, Zoghbi HY. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. Plos Medicine. 4: e182. PMID 17535104 DOI: 10.1371/Journal.Pmed.0040182 |
0.52 |
|
| 2005 |
Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: mechanisms and common principles. Nature Reviews. Genetics. 6: 743-55. PMID 16205714 DOI: 10.1038/nrg1691 |
0.436 |
|
| Show low-probability matches. |